Literature DB >> 21152146

Alcohol withdrawal kindling: is there a role for anticonvulsants?

Vania Modesto-Lowe1, Jessica Huard, Cynthia Conrad.   

Abstract

Animal and clinical studies supporting the kindling hypothesis of alcohol withdrawal suggest the need to revisit current treatment concepts. While traditional approaches have emphasized symptom reduction and prevention of complications, novel approaches include slowing progress of clinical severity associated with multiple withdrawals. Currently, it is unclear if medications can halt cumulative neurotoxicity associated with multiple withdrawals. However, the ability of anticonvulsants to improve the course of alcohol withdrawal and their neuroprotective effects may be of interest. The use of anticonvulsants as probes in animal models of kindling and controlled trials examining the efficacy of newer anticonvulsants in the treatment of alcohol withdrawal may improve understanding of alcohol withdrawal kindling and its treatment.

Entities:  

Year:  2005        PMID: 21152146      PMCID: PMC3000183     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


  74 in total

1.  Neuroprotective effects of anticonvulsants in rat hippocampal slice cultures exposed to oxygen/glucose deprivation.

Authors:  Jens C Rekling
Journal:  Neurosci Lett       Date:  2003-01-02       Impact factor: 3.046

2.  Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal.

Authors:  R Malcolm; J C Ballenger; E T Sturgis; R Anton
Journal:  Am J Psychiatry       Date:  1989-05       Impact factor: 18.112

3.  Divalproex sodium (Depakote) for alcohol withdrawal and relapse prevention.

Authors:  Lance P Longo; Todd Campbell; Sandra Hubatch
Journal:  J Addict Dis       Date:  2002

Review 4.  Kindling as a model for alcohol withdrawal syndromes.

Authors:  J C Ballenger; R M Post
Journal:  Br J Psychiatry       Date:  1978-07       Impact factor: 9.319

Review 5.  Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs.

Authors:  H S White
Journal:  Epilepsia       Date:  1999       Impact factor: 5.864

6.  Effects of gabapentin on brain GABA, homocarnosine, and pyrrolidinone in epilepsy patients.

Authors:  O A Petroff; F Hyder; D L Rothman; R H Mattson
Journal:  Epilepsia       Date:  2000-06       Impact factor: 5.864

Review 7.  Pharmacological mechanisms of naltrexone and acamprosate in the prevention of relapse in alcohol dependence.

Authors:  John Littleton; Walter Zieglgänsberger
Journal:  Am J Addict       Date:  2003

8.  The kindling hypothesis: further evidence from a U.S. national study of alcoholic men.

Authors:  B M Booth; F C Blow
Journal:  Alcohol Alcohol       Date:  1993-09       Impact factor: 2.826

9.  Impact of an alcohol withdrawal syndrome practice guideline on surgical patient outcomes.

Authors:  Karen M Stanley; Celene M Amabile; Kit N Simpson; Deborah Couillard; E Douglas Norcross; Cathy L Worrall
Journal:  Pharmacotherapy       Date:  2003-07       Impact factor: 4.705

10.  A potential contribution to ethanol withdrawal kindling: reduced GABA function in the inferior collicular cortex.

Authors:  T J McCown; G R Breese
Journal:  Alcohol Clin Exp Res       Date:  1993-12       Impact factor: 3.455

View more
  2 in total

1.  Levetiracetam results in increased and decreased alcohol drinking with different access procedures in C57BL/6J mice.

Authors:  Eric W Fish; Abigail E Agoglia; Michael C Krouse; R Grant Muller; J Elliott Robinson; C J Malanga
Journal:  Behav Pharmacol       Date:  2014-02       Impact factor: 2.293

2.  The Use of Anticonvulsant Adjuncts to Treat Alcohol Withdrawal Syndrome in Older Adults.

Authors:  Stefanie Montgomery; Karen Dahri; Kaveh Rayani; Jacqueline Kwok; Peter Chan
Journal:  Can Geriatr J       Date:  2022-03-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.